NAFLD Hepatic Manifestation of Metabolic Syndrome a NAFLD cont Hepatic Manifestation of Metabolic Syndrome a NAFLDNASH Closely Associated With Visceral Obesity Insulin Resistance AASLD ID: 433291
Download Presentation The PPT/PDF document "Addressing the Unmet Need in Nonalcoholi..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Addressing the Unmet Need in Nonalcoholic SteatohepatitisSlide2Slide3
NAFLDHepatic
Manifestation of Metabolic Syndrome
aSlide4
NAFLD (cont)
Hepatic
Manifestation of Metabolic Syndrome
aSlide5
NAFLD/NASH Closely Associated With Visceral Obesity, Insulin ResistanceSlide6
AASLDCurrent Therapeutic Recommendations for NAFLD/NASHSlide7
Pioglitazone vs PlaceboSignificant Improvement of Histologic Features and Insulin SensitivitySlide8
11β-HSD1 Inhibitor RO5093151 Inhibits Adipocyte DifferentiationSlide9
Galectin-3 Binding Drug GR-MD-02 Inhibits Hepatic Injury in Mouse ModelSlide10
Obeticholic Acid Improves Insulin Sensitivity and Markers of Liver InjurySlide11
Selective Serotonin 2C Receptor Agonists Aid Weight LossSlide12
Phentermine and Topiramate ER, an STR, Improves Weight LossSlide13
Incretin Mimetics and Analogs Aid Maintenance of Glucose BalanceSlide14
AbbreviationsSlide15
ReferencesSlide16
References (cont)Slide17
References (cont)